Ad hoc consultation on the harmonised classification and labelling of silanamine
On 5 December 2019, the Committee for Risk Assessment (RAC) adopted an opinion on silanamine, 1,1,1-trimethyl-N- (trimethylsilyl), hydrolysis products with silica; pyrogenic, synthetic amorphous, nano, surface treated silicon dioxide (HMDZ-treated SAS; EC 272-697-1, CAS 68909-20-6), concluding that the substance should be classified as STOT RE 2; H373 (lung) (inhalation) and Acute Tox 2; H330 via the inhalation route (ATE = 0.45 mg/L).
New information has been provided by industry addressing the adopted classification for acute inhalation toxicity. Based on a request from the European Commission, ECHA's Executive Director gave the mandate to RAC to review the existing opinion in relation to the classification for acute inhalation toxicity.
All interested parties are invited to submit comments in direct relation to the subject of the Art. 77 ad hoc consultation by 6 February 2023. The comments will be published on our website.
Give comments
New intentions and proposals to harmonise classification and labelling
Six intentions have been received for:
-
Bronopol (EC 200-143-0, CAS 52-51-7);
-
Benzenamine, N-phenyl-, reaction products with 2,4,4-trimethylpentene; Reaction products of diphenylamine with nonene, branched (EC -, CAS -);
-
1-amino-4-hydroxy-2-phenoxyanthraquinone (EC 241-442-6, CAS 17418-58-5);
-
2-amino-2-methylpropanol (EC 204-709-8, CAS 124-68-5);
-
Methyl isothiocyanate (EC 209-132-5, CAS 556-61-6); and
-
1,3-diphenylguanidine (EC 203-002-1, CAS 102-06-7).
One proposal has been submitted for (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate; fosthiazate (ISO) (EC 619-377-3, CAS 98886-44-3).
Two withdrawals have been received for:
Registry of CLH intentions until outcome
|
